Retatrutide may be considered for adults who: Have overweight or obesity Struggle with insulin resistance or metabolic dysfunction Have not achieved desired results with lifestyle changes alone Want structured medical guidance and monitoring Your provider will help determine whether retatrutide or another therapy is the best option for you
While these medications can be highly effective, they may cause side effects such as nausea, vomiting, and decreased appetite
Weight loss results usually follow a compounding curve: Weeks 14: Initial water weight reduction and a slight decrease in food intake
It's important to note that Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management, while Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management, though sometimes used off-label for weight loss
Cuntos kilos se bajan con el Ozempic
Think of it as the system that connects you to a doctor and then gets your medication to your door